Abstract:Young, James B., M. Elizabeth Bü rgi-Saville, Ulrich Bü rgi, and Lewis Landsberg. Sympathetic nervous system activity in rat thyroid: potential role in goitrogenesis. Am J Physiol Endocrinol Metab 288: E861-E867, 2005. First published December 7, 2004; doi:10.1152/ajpendo.00292.2004.-The role of sympathetic innervation in regulation of thyroid function is incompletely understood. We, therefore, carried out studies in rats utilizing techniques of norepinephrine turnover to assess thyroid sympathetic activity i… Show more
“…The sympathetic nervous system (SNS) interacts closely with the HPT axis to regulate both energy expenditure and thyroid gland responsiveness to TSH. It is possible that suppression of TSH might be accompanied by modulation of the SNS both to normalize energy expenditure and normalize plasma T3 [25]. The effects of repeated H3 administration differ from those of other orexigenic peptides such as NPY, AgRP and ghrelin.…”
The effects of acute and repeated intraparaventricular (iPVN) administration of human relaxin-3 (H3) were examined on food intake, energy expenditure, and the hypothalamic-pituitary thyroid axis in male Wistar rats. An acute high dose iPVN injection of H3 significantly increased food intake 1 hour post-administration [0.4 ± 0.1g (vehicle) vs 1.6 ± 0.5g (180pmol H3), 2.4 ± 0.5g (540pmol H3) and 2.2 ± 0.5g (1620pmol H3), p< 0.05 for all doses vs vehicle]. Repeated iPVN H3 injection (180pmol/twice a day for 7 days) significantly increased cumulative food intake in ad libitum fed animals compared with vehicle [211.8 ± 7.1g (vehicle) vs 261.6 ± 6.7g (ad libitum fed H3), p< 0.05]. Plasma leptin was increased in the H3 ad libitum fed group. Plasma thyroid stimulating hormone was significantly decreased after acute and repeated administration of H3. These data suggest H3 may play a role in longterm control of food intake.
“…The sympathetic nervous system (SNS) interacts closely with the HPT axis to regulate both energy expenditure and thyroid gland responsiveness to TSH. It is possible that suppression of TSH might be accompanied by modulation of the SNS both to normalize energy expenditure and normalize plasma T3 [25]. The effects of repeated H3 administration differ from those of other orexigenic peptides such as NPY, AgRP and ghrelin.…”
The effects of acute and repeated intraparaventricular (iPVN) administration of human relaxin-3 (H3) were examined on food intake, energy expenditure, and the hypothalamic-pituitary thyroid axis in male Wistar rats. An acute high dose iPVN injection of H3 significantly increased food intake 1 hour post-administration [0.4 ± 0.1g (vehicle) vs 1.6 ± 0.5g (180pmol H3), 2.4 ± 0.5g (540pmol H3) and 2.2 ± 0.5g (1620pmol H3), p< 0.05 for all doses vs vehicle]. Repeated iPVN H3 injection (180pmol/twice a day for 7 days) significantly increased cumulative food intake in ad libitum fed animals compared with vehicle [211.8 ± 7.1g (vehicle) vs 261.6 ± 6.7g (ad libitum fed H3), p< 0.05]. Plasma leptin was increased in the H3 ad libitum fed group. Plasma thyroid stimulating hormone was significantly decreased after acute and repeated administration of H3. These data suggest H3 may play a role in longterm control of food intake.
“…The OGF-OGFr axis increases p16 and p21 cyclin-dependent kinase inhibitors that decrease the phosphorylation of RB protein and block the transit of cells from G 1 to S phases of the cell cycle, thereby depressing cell proliferation (30,31). The source of OGF in thyroid tissues is unclear but may be autocrine, as well as paracrine from sympathetic nerve terminals, peri=parafollicular immunocytes, thyroid stroma interstitium, and=or endothelium of thyroidal vessels including capillaries (42,43). If the OGFOGFr system modulates cell replication and consequent growth in thyroid disorders through an inhibitory pathway, then administration of exogenous OGF, upregulation of endogenous OGF, attenuating the degradation of OGF, or increasing the number and=or affinity of OGF receptors could exert a potent negative influence on the progression of these malignant and nonmalignant conditions.…”
The finding that a potent negative growth regulator and its receptor are present in nonmedullary thyroid cancers and thyroid tissues from patients with nonmalignant disease lead us to suggest that the OGF-OGFr axis serves as a regulator of cell proliferation in these tissues. Moreover, modulation of this biological system may be used to treat progression of nonmedullary thyroid neoplasias.
“…This method was used extensively by Landsberg and Young in their seminal studies of sympathetic drive under various metabolic challenges, diets and hormonal states ( e.g. , [172;312–314]). More specifically, the method is based on the uptake and subsequent decline in 3 NE such that fractional turnover (slope of the decline) and NETO [NE released per gram of tissue per hour [170]] can be determined.…”
Section: Preclinical and Clinical Measures Of Sns Activitymentioning
White adipose tissue (WAT) is innervated by the sympathetic nervous system (SNS) and its activation is necessary for lipolysis. WAT parasympathetic innervation is not supported. Fully-executed SNS-norepinephrine (NE)-mediated WAT lipolysis is dependent on β-adrenoceptor stimulation ultimately hinging on hormone sensitive lipase and perilipin A phosphorylation. WAT sympathetic drive is appropriately measured by electrophysiological and neurochemical (NE turnover) in non-human animals and this drive is fat pad-specific preventing generalizations among WAT depots and non-WAT organs. Leptin-triggered SNS-mediated lipolysis is weakly supported, whereas insulin or adenosine inhibition of SNS/NE-mediated lipolysis is strongly supported. In addition to lipolysis control, increases or decreases in WAT SNS drive/NE inhibit and stimulate white adipocyte proliferation, respectively. WAT sensory nerves are of spinal-origin and sensitive to local leptin and increases in sympathetic drive, the latter implicating lipolysis. Transsynaptic viral tract tracer use revealed WAT central sympathetic and sensory circuits including SNS-sensory feedback loops that may control lipolysis.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.